NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-182-2019-2-US-01 RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER US CON 19/381,783 Pending
NIAID E-135-2025-0-ZA-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE ZA National Stage 2025/09361 Pending
NCI E-038-2024-0-PC-01 ACYLOXYACYL HYDROLASE AND METHODS OF USE PCT PCT PCT/US2025/053940 Pending
NINDS E-061-2023-0-EP-01 SYSTEMS AND METHODS FOR PATTERNED MULTI-SLICE EXCITATION IN MAGNETIC RESONANCE IMAGING EP National Stage 24725979.9 Pending
NCI E-167-2019-0-EP-02 T CELL PHENOTYPES ASSOCIATED WITH RESPONSE TO ADOPTIVE CELL THERAPY EP DIV 25213138.8 Pending
NHLBI E-017-2024-2-PC-01 SYSTEMS AND METHODS FOR A MYOCARDIAL ACCESSOR CATHETER FOR INTRAMYOCARDIAL ABLATION PCT PCT COMB PCT/US2025/053825 Pending
NHLBI E-017-2024-1-PC-01 SYSTEMS AND METHODS FOR AN ABLATION CATHETER FOR INTRAMYOCARDIAL ABLATION PCT PCT COMB PCT/US2025/053823 Pending
NIAID E-279-2016-1-US-12 HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE US CON 19/376,412 Pending
NIEHS E-164-2023-0-US-02 APOE-ACTIVATING NONCODING RNA (ERNA) AND USES THEREOF US National Stage 19/480,540 Pending
NCI E-054-2023-0-CN-01 T CELL RECEPTORS TARGETING Y220C OR R175H MUTATION IN P53 CN National Stage 202480029232.1 Pending
NIAID E-135-2025-0-SG-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE SG National Stage 11202507304S Pending
NIAID E-135-2025-0-CA-01 RESPIRATORY SYNCYTIAL VIRUS VACCINE AND METHODS OF USE CA National Stage 3290683 Pending
NICHD E-229-2023-0-PC-01 HYDROPHYSIOLOGY MAGNETIC RESONANCE METHOD PCT PCT PCT/US2025/053011 Pending
NCI E-226-2014-0-EP-02 ANTI-THYROGLOBULIN T CELL RECEPTORS EP DIV 25211314.7 Abandoned
NIDCR E-130-2023-0-EP-01 TREATMENT OF HYPOPARATHYROIDISM USING TRIPHENYL CALCILYTIC COMPOUNDS EP National Stage 24730090.8 Pending
NHGRI E-134-2023-0-US-02 SYNTHETIC MMAB GENES AND AAV VECTORS TO TREAT COBALAMIN B DEFICIENCY US National Stage 19/478,200 Pending
NCI E-136-2023-0-EP-01 1-THIOXO-2,4-DIHYDROTHIENO[2,3-E] [1,2,4]TRIAZOLO[4,3-A]PYRIMIDIN - 5(1H)-ONE DERIVATIVES AS ALLOSTERIC INHIBITORS OF THE POLO-LIKE KINASE 1 (PLK1) POLO BOX DOMAIN (PBD) FOR THE TREATMENT OF CANCER EP National Stage 24722387.8 Pending
NCI E-264-2015-0-CA-04 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4)AND METHODS OF THEIR USE CA DIV 3289997 Pending
NCATS E-168-2019-0-JP-01 RADIAL GLIA AND ASTROCYTE DIFFERENTIATION FROM HUMAN
PLURIPOTENT STEM CELLS 		JP DIV 2025-177735 Pending
NCI E-054-2023-0-EP-01 T CELL RECEPTORS TARGETING Y220C OR R175H MUTATION IN P53 EP National Stage 24721308.5 Pending
CC E-217-2024-0-PCT-01 WEARABLE SPIROMETRY UTILIZING A NON-INVASIVE MOTION SENSOR FOR MEASURING A VOLUME OF INSPIRATION PCT PCT PCT/US2025/051782 Pending
NCI E-054-2023-0-KR-01 T CELL RECEPTORS TARGETING Y220C OR R175H MUTATION IN P53 KR National Stage 10-2025-7035226 Pending
NCATS E-113-2023-0-HK-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF HK EP 62025114039.3 Pending
NIAID E-086-2020-0-IL-18 SARS-CoV-2 VACCINE IL DIV 324082 Pending
NIDCR E-130-2023-0-JP-01 TREATMENT OF HYPOPARATHYROIDISM USING TRIPHENYL CALCILYTIC COMPOUNDS JP National Stage 2025-561243 Pending
NCI E-143-2024-0-PC-01 METHODS OF PREPARING CELL THERAPY PRODUCTS FOR THE TREATMENT OF CONDITIONS CAUSED BY HUMAN PAPILLOMAVIRUS 6 OR 11 INFECTION PCT PCT PCT/US2025/051640 Pending
NCI E-042-2014-0-EP-01 Chimeric Antigen Receptors Targeting CD-19 EP DIV 25209657.3 Pending
NIDCR E-130-2023-0-US-02 TREATMENT OF HYPOPARATHYROIDISM USING TRIPHENYL CALCILYTIC COMPOUNDS US National Stage 19/477,041 Pending
NIDA E-077-2019-0-US-07 D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF US CON 19/363,336 Pending
NIMH E-070-2023-0-EP-01 SYSTEMS AND METHODS FOR MULTICHANNEL INDIVIDUALIZED STIMULATION THERAPY EP National Stage 24723369.5 Pending
NEI E-131-2022-0-EP-01 METHODS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION EP National Stage 24720357.3 Pending
NCI E-188-2025-0-PC-01 AUTOPHAGY MODULATORS AND METHODS OF USE PCT PCT PCT/US2025/051307 Pending
NIDA E-053-2023-0-EP-01 FLUORINATED MU-OPIOID RECEPTOR AGONISTS EP National Stage 23837885.5 Pending
NHLBI E-224-2024-0-PC-01 IL-2 MUTEINS AND THEIR USE PCT PCT PCT/US2025/051121 Pending
NCI E-125-2024-0-PC-01 INTEGRASE STRAND TRANSFER INHIBITORS HAVING
STRUCTURES OF PHENYL OR ARYL SUBSITTUTION AT THE 6-POSITION OF A 1-HYDROXY-1, 8-NAPHTHYRIDIN2(1H)-ONE BASED METAL CHELATING 		PCT PCT PCT/US2025/051090 Pending
NCI E-068-2018-0-EP-01 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 EP DIV 25208165.8 Pending
NIA E-151-2017-0-US-13 FATTY ACID DERIVATIVES AND THEIR USE US CON 19/356,831 Abandoned
NCI E-080-2014-0-US-07 ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY US DIV 19/356,663 Pending
NEI E-015-2019-0-IL-01 BIODEGRADABLE TISSUE REPLACEMENT IMPLANT AND ITS USE IL DIV 323893 Pending
NIAID E-266-2023-0-EP-02 Conductive Polymer Coated Electrodes for Dielectrophoretic Cell Positioning and Electroporation EP National Stage 24708870.1 Pending
NHGRI E-222-2024-0-PC-01 ADENO ASSOCIATED VIRAL (AAV) VECTORS FOR TREATMENT OF PROPIONIC ACIDEMIA (PA) CAUSED BY MUTATIONS IN PROPIONYL-COA CARBOXYLASE BETA (PCCB) PCT PCT PCT/US2025/050511 Pending
NIAID E-159-2024-0-PC-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3
EXPRESSING AVIAN INFLUENZA VIRUS PROTEINS AND USE THEREOF 		PCT PCT PCT/US2025/050239 Pending
NEI E-249-2023-0-PC-01 ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY (EIS) DEVICE TO RESOLVE INDIVIDUAL MEMBRANE ELECTRICAL PROPERTIES OF EPITHELIAL AND ENDOTHELIAL TISSUES PCT PCT PCT/US2025/050192 Pending
NCI E-186-2025-0-PC-01 AUTOPHAGY INHIBITOR THAT TARGETS THE ATG14L-BECLIN1 PROTEIN-PROTEIN INTERACTION PCT PCT PCT/US2025/050250 Pending
NIMH E-070-2023-0-US-02 SYSTEMS AND METHODS FOR MULTICHANNEL INDIVIDUALIZED STIMULATION THERAPY US National Stage 19/474,167 Pending
NIAID E-064-2015-3-US-02 MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE US CON 19/352,878 Pending
NIAAA E-172-2024-0-PC-01 COMPOSITIONS AND METHODS FOR TREATING FIBROTIC AND INFLAMMATORY DISEASES PCT PCT PCT/US2025/049791 Pending
NCATS E-041-2021-3-IN-01 Combinations of Retinaldehyde Dehydrogenase 1 (RALDH1) Inhibitors and Immunostimulators and Methods Using Same IN National Stage 202517095866 Pending
NCI E-166-2023-0-PC-01 CANCER VACCINE AND METHOD OF USE THEREOF PCT PCT PCT/US2025/049357 Pending
NIAID E-215-2016-1-US-02 PREFUSION PIV F IMMUNOGENS AND THEIR USE US CON 19/348,478 Pending